1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina C.; Bajaj, Anshika; Archer, Jacob F.; Reeves, Rebecca S.; Ngo, Lisa Y.; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fu... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy. (29th January 2019) Authors: Alqahtani, Ali; Choucair, Khalil; Ashraf, Mushtaq; Hammouda, Danae M; Alloghbi, Abduraham; Khan, Talal; Senzer, Neil; Nemunaitis, John Journal: Future science OA Issue: Volume 5:Number 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Case Report: Immune-mediated Complete Response in a Patient With Recurrent Advanced Ewing Sarcoma (EWS) After Vigil Immunotherapy. Issue 4 (May 2017) Authors: Ghisoli, Maurizio; Rutledge, McCarley; Stephens, Philip J.; Mennel, Robert; Barve, Minal; Manley, Meghan; Oliai, Bahram R.; Murphy, Kathleen M.; Manning, Luisa; Gutierrez, Belen; Rangadass, Priyanka; Walker, Ashli; Wang, Zhaohui; Rao, Donald; Adams, Ned; Wallraven, Gladice; Senzer, Neil; Nemunait... Journal: Journal of pediatric hematology/oncology Issue: Volume 39:Issue 4(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Ewing's Sarcoma: Development of RNA Interference-Based Therapy for Advanced Disease. (11th March 2012) Authors: Simmons, Olivia; Maples, Phillip B.; Senzer, Neil; Nemunaitis, John Other Names: Fang B. Academic Editor.; Kuhnel F. Academic Editor.; Stracke M. Academic Editor. Journal: ISRN oncology Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Final planned overall survival (OS) from OPTiM, a randomized Phase III trial of talimogene laherparepvec (T-VEC) versus GM-CSF for the treatment of unresected stage IIIB/C/IV melanoma (NCT00769704). (6th November 2014) Authors: Andtbacka, Robert HI; Collichio, Frances A; Amatruda, Thomas; Senzer, Neil; Chesney, Jason; Delman, Keith; Spitler, Lynn; Puzanov, Igor; Agarwala, Sanjiv; Milhem, Mohammed; Harrington, Kevin; Middleton, Mark; Li, Ai; Shilkrut, Mark; Coffin, Robert; Kaufman, Howard Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Relationships of clinical response to relevant molecular signal during Phase I testing of Aurora Kinase A inhibitor: Retrospective assessment. Issue 5 (2015) Authors: Nemunaitis, John; Blend, Christopher; Bien-Willner, Gabriel; Degele, Meghan; Roth, Alyssa; Hayes, Stacey; Plato, Leah; Andrew, Andrew; Nemunaitis, James; Jackson, David B.; Senzer, Neil Journal: Integrative molecular medicine Issue: Volume 2:Issue 5(2015:Oct.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Reversible Masking Using Low-Molecular-Weight Neutral Lipids to Achieve Optimal-Targeted Delivery. (10th May 2012) Authors: Templeton, Nancy Smyth; Senzer, Neil Other Names: Quaglia Fabiana Academic Editor. Journal: Journal of drug delivery Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Systemic versus local responses in melanoma patients treated with talimogene laherparepvec from a multi-institutional phase II study. Issue 1 (December 2016) Authors: Kaufman, Howard; Amatruda, Thomas; Reid, Tony; Gonzalez, Rene; Glaspy, John; Whitman, Eric; Harrington, Kevin; Nemunaitis, John; Zloza, Andrew; Wolf, Michael; Senzer, Neil Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗